RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

Goat Funded Futures vs Lirunex

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

GFFU

Goat Funded Futures

LRNX

Lirunex

GOAT FUNDED FUTURES

METRIC

LIRUNEX

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

MAX FUNDING

—

MIN COST

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

GOAT FUNDED FUTURES DETAILS

STEPS: -phase
MARKETS: Futures

LIRUNEX DETAILS

STEPS: -phase

Goat Funded Futures PROS

+Listed as a futures firm, providing access to an asset class not offered by all prop firms.
+Hong Kong base may offer access to Asian market hours and related futures instruments.
+Futures markets offer high liquidity and defined contract structures attractive to professional traders.
+Specialisation in futures suggests a focused and potentially expert evaluation framework.

Goat Funded Futures CONS

−No trading data has been provided for this firm, making objective comparison impossible.
−Without profit split, drawdown, funding levels, or challenge cost, no industry benchmarks can be applied.
−Traders cannot assess suitability or value without disclosure of core terms and conditions.

Lirunex PROS

+Country of operation is listed as Hong Kong, indicating an established international jurisdiction.
+A registered tag suggests some formal industry presence.
+No confirmed below-average financial metrics are currently on record.
+Listing on a comparison platform indicates an intent toward transparency.

Lirunex CONS

−No trading or financial metrics are available to evaluate this firm objectively.
−Without data on profit split, funding, or costs, no comparison to industry averages is possible.
−Traders cannot assess payout speed, drawdown rules, or profit targets from available data.

PROPDNA VERDICT